“When-issued” trading expected to begin on or about June 12, 2024 Record date for distribution of GRAIL shares will be June 13, 2024 Distribution date for GRAIL shares anticipated to be June 24, 2024 SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced that its Board of Directors has approved the spin-off of GRAIL. GRAIL is […]

Collaboration leverages synergies of QIAGEN’s OmicSoft omics data through Evotec’s analysis platform PanHunter Customers accelerate target discovery decisions with high-quality multi-omic evidence, and expanded analysis capabilities Hamburg, Germany, and Venlo, the Netherlands — Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) and QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a […]

LGC has today announced that Marcus Kaeller will join its Board of Directors and Executive Leadership Team (ELT) as Chief Financial Officer (CFO), effective 3rd June 2024.  Marcus succeeds Vivid Sehgal, who will leave LGC after almost two and a half years of service.  Over the past several months, Vivid has worked closely with the LGC […]

BERLIN, Germany – MGI (MGI Tech Co., Ltd. or its subsidiaries, together referred to MGI), a company committed to building core tools and technologies that drive innovation in life science, today announced the opening of its new European headquarters in Berlin, Germany to support the life science community across the region. “We chose Berlin for […]

Applied Biosystems™ CytoScan™ Dx and Chromosome Analysis Suite (ChAS) Dx software provide complete solution to support cytogenetic testing CARLSBAD, Calif. —  Thermo Fisher Scientific Inc., the world leader in serving science, announced today that the Applied Biosystems™ CytoScan™ Dx Assay and Applied Biosystems™ Chromosomal Analysis Suite (ChAS) Dx software now comply with In Vitro Diagnostic […]

Next-generation-sequencing-based homologous recombination deficiency (HRD) assay based on QIAGEN’s QIAseq xHYB technology, QIAGEN Digitial Insight solutions, and Myriad’s proprietary, FDA-approved MyChoice CDx® biomarkers QIAGEN to make kit-based HRD test available globally to support research and companion diagnostics development in collaboration with pharmaceutical partners enabling wider adoption and potential clinical indication expansion for MyChoice CDx Project […]

City University of New York Partners with Genestack to Enhance AI readiness of Life Science Data in the Bioconductor Program Cambridge, UK – CUNY (City University of New York) and Genestack Ltd are pleased to announce their collaboration aimed at streamlining data curation for the BioConductor program. This innovative partnership brings together the expertise of CUNY […]

New collective intelligence network to enable the most advanced research in oncology in support of precision medicine BOSTON and ROLLE, Switzerland — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced SOPHiA UNITY, a new data-driven consortium designed to accelerate cancer research globally. SOPHiA UNITY aims to bring together leading […]

The Dovetail AssemblyLink Assay empowers researchers to assemble high-quality genomes in record time, accelerating efforts to conserve Earth’s incredible biodiversity BOSTON, MASS. — Dovetail Genomics today announces the Dovetail® AssemblyLink™ Assay, a transformative genomics tool designed to redefine the standards of speed and quality in genomic assembly. Built upon Dovetail’s core LinkPrep™ Technology, the AssemblyLink Assay streamlines […]

New cloud platform facilitates streamlined, end-to-end analysis of single cell data SEATTLE — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the availability of Trailmaker™, its user-friendly cloud platform purpose-built for single cell data analysis. Fast, scalable, and capable of providing end-to-end analysis, Trailmaker removes common analysis barriers, rapidly transforming […]